DOI QR코드

DOI QR Code

Spectrophotometric Determination of Some Fluoroquinolone Antibacterials through Charge-transfer and Ion-pair Complexation Reactions

  • Published : 2004.03.20

Abstract

Two simple, rapid and sensitive spectrophotometric methods for the determination of three fluoroquinolones, namely levofloxacin, norfloxacin and ciprofloxacin have been performed either in pure form or in their tablets. In the first method, levofloxacin and norfloxacin are directly treated with bromocresol green (BCG) in dichloromethane while ciprofloxacin is allowed to react with the same dye in aqueous acidic buffer. Highly yellow colored complex species were formed instantaneously in case of levofloxacin and norfloxacin or after extraction into dichloromethane for ciprofloxacin. The formed complexes are quantified spectrophotometrically at their absorption maxima at 411 nm for levofloxacin and 412 nm for norfloxacin and ciprofloxacin. The second method involves the reaction of levofloxacin with ${\rho}$-chloranilic acid ( ${\rho}$-CA) and norfloxacin with tetracyanoethylene (TCNE) in acetonitrile to give complexes with maximum absorbance at 521 and 333 nm for the two drugs, respectively. Adopting the first procedure, calibration graphs were linear over the range 1- 20 ${\mu}g\;mL^{-1}$ with mean percentage recoveries of 100.41 ${\pm}$ 0.72, 99.99 ${\pm}$ 0.54 and 100.23 ${\pm}$ 0.91 for the theree drugs, respectively. For the second procedure, the concentration ranges were 15-250 ${\mu}g\;mL^{-1}$ for levofloxacin using ${\rho}$-CA and 0.8-16 ${\mu}g\;mL^{-1}$ for norfloxacin using TCNE with mean percentage recoveries of 99.88 ${\pm}$ 0.45 and 100.26 ${\pm}$ 0.68 for the two drugs, respectively. The proposed methods were successfully applied to determine these drugs in their tablet formulations and the results compared favorably to that of reference methods. The proposed methods are recommended for quality control and routine analysis.

Keywords

References

  1. Wood, D. G.; Slack, R.; Peutherer, J. Medical Microbiology, 15thEd.; Harcourt Brace and Company Limited: UK, 1998; p 52.
  2. Martindale, The Extra Pharmacopoeia, 32nd ed.; The PharmaceuticalPress: London, 1999.
  3. United States Pharmacopoeia XXV; National Formulary XX; US pharmacopoeial convention: Rockville, MD, 2002.
  4. The British pharmacopoeia; HMSO: London, 1998.
  5. Rizk, M.; Belal, F.; Ibrahim, F.; Ahmed, S. M.; El-Enany, N. M.Sci. Pharm. 2000, 68, 173.
  6. Ramana-Rao, G.; Avadhanulu, A. B.; Vatsa, D. K. Indian Drugs1990, 27, 532.
  7. Suslu, I.; Tamer, A. Anal. Lett. 2003, 36, 1163. https://doi.org/10.1081/AL-120020151
  8. Issa, Y. M.; Abdel-Gawad, F. M.; Abou-Table, M. A.; Hussein, H.M. Anal. Lett. 1997, 30, 2071. https://doi.org/10.1080/00032719708001722
  9. Sastry, C. S. P.; Rama-Rao, K.; Prasad, D. S. Talanta 1995, 42,311. https://doi.org/10.1016/0039-9140(95)01380-T
  10. Djurdjevic, P.; Todorovic, M.; Stankov, M. J.; Odovic, J. Anal.Lett. 2000, 33, 657. https://doi.org/10.1080/00032710008543081
  11. Suliman, F. E. O.; Sultan, S. M. Talanta 1996, 43, 559. https://doi.org/10.1016/0039-9140(95)01771-2
  12. Nagaralli, B. S.; Seetharamappa, J.; Melwanki, M. B. J. Pharm.Biomed. Anal. 2002, 29, 859. https://doi.org/10.1016/S0731-7085(02)00210-8
  13. Rizk, M.; Belal, F.; Ibrahim, F.; Ahmed, S.; Sheribah, Z. A. J.AOAC Int. 2001, 84, 368.
  14. Mostafa, S.; El-Sadek, M.; Alla, E. A. J. Pharm. Biomed. Anal.2002, 27, 133. https://doi.org/10.1016/S0731-7085(01)00524-6
  15. Feng, Y.; Zhao, F. L.; Tong, S. Y. Fenxi Kexue Xuebao 2000, 16,184.
  16. Zhao, F. L.; Xu, B. Z.; Zhang, Z. Q.; Tong, S. Y. J. Pharm.Biomed. Anal. 1999, 21, 355. https://doi.org/10.1016/S0731-7085(99)00121-1
  17. Abdel-Gawad, F. M.; Issa, Y. M.; Fahmy, H. M.; Hussein, H. M.Mikrochim Acta 1998, 130, 35. https://doi.org/10.1007/BF01254588
  18. Xuan, C. S.; Wang, Z. Y.; Song, J. L. Anal. Lett. 1998, 31, 1185. https://doi.org/10.1080/00032719808002855
  19. El-Walily, A. F. M.; Belal, S. F.; Bakry, R. S. J. Pharm. Biomed.Anal. 1996, 14, 561. https://doi.org/10.1016/0731-7085(95)01662-7
  20. Kilic, E.; Koseoglu, F.; Akay, M. A. J. Pharm. Biomed. Anal.1994, 12, 347. https://doi.org/10.1016/0731-7085(94)90010-8
  21. El-Ansary, A. L.; El-Hawary, W. F.; Issa, Y. M.; Ahmed, A. F.Anal. Lett. 1999, 32, 2255. https://doi.org/10.1080/00032719908542968
  22. Vilchez, J. L.; Ballesteros, O.; Taoufiki, J.; Sanchez-Palencia, G.;Navalon, A. Anal. Chim. Acta 2001, 444, 279. https://doi.org/10.1016/S0003-2670(01)01238-7
  23. Ocana-Gonzalez, J. A.; Callejon-Mochon, M.; Barragan-dela-Rosa, F. L. Talanta 2000, 52, 1149. https://doi.org/10.1016/S0039-9140(00)00484-7
  24. Drakopoulos, A. L.; Ioannou, P. C. Anal. Chim. Acta 1997, 354,197. https://doi.org/10.1016/S0003-2670(97)00465-0
  25. Aly, F. A.; Al-Tamimi, S. A.; Alwarthan, A. A. Talanta 2001, 53, 885. https://doi.org/10.1016/S0039-9140(00)00590-7
  26. Ocana, J. A.; Callejon, M.; Barragan, F. J. Analyst 2000, 125,1851. https://doi.org/10.1039/b004252h
  27. Belal, F.; Rizk, M.; Aly, F. A.; El-Enany, N. M. Chem. Anal.(Warsaw) 1999, 44, 763.
  28. Ghoneim, M. M.; Radi, A.; Beltagi, A. M. J. Pharm. Biomed.Anal. 2001, 25, 205. https://doi.org/10.1016/S0731-7085(00)00475-1
  29. Rizk, M.; Belal, F.; Aly, F. A.; El-Enany, N. M. Talanta 1998, 46,83. https://doi.org/10.1016/S0039-9140(97)00249-X
  30. Altiokka, G.; Atkosar, Z.; Can, N. O. J. Pharm. Biomed. Anal.2002, 30, 881. https://doi.org/10.1016/S0731-7085(02)00354-0
  31. Argekar, A. P.; Sawant, J. G. J. Planar Chromatogr.; Mod TLC1999, 12, 202.
  32. Neckel, U.; Joukhadar, C.; Frossard, M.; Jaeger, W.; Mueller, M.;Mayer, B. X. Anal. Chim. Acta 2002, 463, 199. https://doi.org/10.1016/S0003-2670(02)00429-4
  33. Wong, F. A.; Juzwin, S. J.; Flor, S. C. J. Pharm. Biomed. Anal.1997, 15, 765. https://doi.org/10.1016/S0731-7085(96)01890-0
  34. Wang, W.; Lu, J. D.; Fu, X. Y.; Chen, Y. Z. Anal. Lett. 2001, 34,569. https://doi.org/10.1081/AL-100002596
  35. Fierens, C.; Hillaert, S.; van-den-Bossche, W. J. Pharm. Biomed.Anal. 2000, 22, 763. https://doi.org/10.1016/S0731-7085(99)00282-4
  36. El-Sherif, Z. A.; Mohamed, A. O.; Walash, M. I.; Tarras, F. M. J.Pharm. Biomed. Anal. 2000, 22, 13. https://doi.org/10.1016/S0731-7085(99)00239-3
  37. Moustafa, A. A. M. J. Pharm. Biomed. Anal. 2000, 22, 45. https://doi.org/10.1016/S0731-7085(99)00275-7
  38. Rahman, N.; Hejaz-Azmi, S. N. J. Pharm. Biomed. Anal. 2000,24, 33. https://doi.org/10.1016/S0731-7085(00)00409-X
  39. Gorog, S. Ultraviolet-Visible Spectrophotometry in PharmaceuticalAnalysis; CRC Press Inc.: Florida, 1995; p 188.
  40. Foster, R. Organic Charge-Transfer Complexes; Academic Press:London, New York, 1969.
  41. Khashaba, P. Y.; El-Shabouri, S. R.; Emara, K. M.; Mohamed, A.M. J. Pharm. Biomed. Anal. 2000, 22, 363. https://doi.org/10.1016/S0731-7085(99)00280-0
  42. Abdellatef, H. E. J. Pharm. Biomed. Anal. 1998, 17, 1267. https://doi.org/10.1016/S0731-7085(97)00254-9
  43. El-Ansary, A. L.; Issa, Y. M.; Selim, W. Anal. Lett. 1999, 32,955. https://doi.org/10.1080/00032719908542869
  44. Walash, M. I.; Rizk, M.; El-Brashy, A. Pharm. Weekbl. Sci. Ed.1986, 8, 234. https://doi.org/10.1007/BF01957784
  45. Taha, A. M.; El-Rabbat, N. A.; Fattah, F. A. J. Pharm. Belg. 1980,35, 437.
  46. Askal, H. F.; Saleh, G. A.; Omar, N. M. Analyst 1991, 116, 387. https://doi.org/10.1039/an9911600387
  47. Job, P. Spectrochemical Methods of Analysis; Wiley Intersience:New York, 1971; p 346
  48. Rose, J. Advanced Physico-chemical Experiments; Pitman: London,1964; p 54.
  49. Caulcut, R.; Boddy, R. Statistics for Analytical Chemists; Chapmann& Hall: London, 1983.

Cited by

  1. Spectrophotometric Methods for the Determination of Fluoroquinolones: A Review vol.38, pp.1, 2008, https://doi.org/10.1080/10408340701804400
  2. Chemiluminescence and Spectrofluorimetric Methods for Determination of Fluoroquinolones: A Review vol.44, pp.9, 2011, https://doi.org/10.1080/00032719.2010.520392
  3. Spectrophotometric Determination of Some Fluoroquinolone Antibacterials by Ion-pair Complex Formation with Cobalt (II) Tetrathiocyanate vol.52, pp.1, 2013, https://doi.org/10.1002/jccs.200500012
  4. Review of Properties and Analytical Methods for the Determination of Norfloxacin vol.46, pp.1, 2016, https://doi.org/10.1080/10408347.2014.941456
  5. Ion-pair complexes formation between fluoroquinolone antibiotics and methyl red and their use for the extraction-spectrophotometric analysis vol.35, pp.7-8, 2017, https://doi.org/10.1177/0263617417703510
  6. Determination of Fluoroquinolones in Pharmaceutical Formulations by Extractive Spectrophotometric Methods Using Ion-Pair Complex Formation with Bromothymol Blue vol.2018, pp.2090-8873, 2018, https://doi.org/10.1155/2018/8436948
  7. Evaluation of N-Bromosuccinimide as a New Analytical Reagent for the Spectrophotometric Determination of Fluoroquinolone Antibiotics vol.55, pp.11, 2007, https://doi.org/10.1248/cpb.55.1551
  8. High Catalytic Efficiency of Nanostructured Molybdenum Trioxide in the Benzylation of Arenes and an Investigation of the Reaction Mechanism vol.15, pp.3, 2009, https://doi.org/10.1002/chem.200801153
  9. Spectrophotometric determination of some fluoroquinolone antibacterials by binary complex formation with xanthene dyes vol.59, pp.10, 2004, https://doi.org/10.1016/j.farmac.2004.07.001
  10. Spectrophotometric and Atomic Absorption Spectroscopic Determination of Some Fluoroquinolone Antibacterials by Ion-pair Complex Formation with Bismuth (III) Tetraiodide vol.52, pp.2, 2004, https://doi.org/10.1002/jccs.200500038
  11. Development and validation of novel analytical methods for estimation of doxofylline in bulk and dosage forms vol.2, pp.3, 2004, https://doi.org/10.5155/eurjchem.2.3.372-377.396
  12. Detection and Measurement of Surface Electron Transfer on Reduced Molybdenum Oxides (MoOx) and Catalytic Activities of Au/MoOx vol.124, pp.16, 2004, https://doi.org/10.1002/ange.201105922
  13. Detection and Measurement of Surface Electron Transfer on Reduced Molybdenum Oxides (MoOx) and Catalytic Activities of Au/MoOx vol.51, pp.16, 2012, https://doi.org/10.1002/anie.201105922
  14. Development and validation of a simple UV spectrophotometric method for the determination of levofloxacin both in bulk and marketed dosage formulations vol.2, pp.6, 2004, https://doi.org/10.1016/j.jpha.2012.06.004
  15. New Sensitive Derivatization Methodology of Levofloxacin Antibiotic from its Dosage Formulations: Kinetic Spectrophotometric Methods for Determination vol.10, pp.5, 2004, https://doi.org/10.1080/22297928.2020.1844594